Clinical trial
Anti-VEGF Therapy for Acute Thyroid Eye Disease (AcTED Study)
NCT04311606 is registered in ClinicalTrials.gov with Massachusetts Eye and Ear Infirmary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anti-VEGF Therapy for Acute Thyroid Eye Disease (AcTED Study)
- Lead sponsor
- Massachusetts Eye and Ear Infirmary
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 2, 2020
- Completion date
- December 17, 2024
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
thyroid eye disease